Active Ingredient: FAMOTIDINE
The literature data on famotidine-induced arrhythmias is conflicting, but precaution is advised by the FDA as QT prolongation cases are being reported
https://www.fda.gov/media/178811/download, https://doi.org/10.1016/S0002-9343(99)00328-9, https://doi.org/10.1016/j.amjcard.2004.02.025, https://doi.org/10.1016/S0014-2999(03)01559-0, https://doi.org/10.1007/s12012-014-9285-8